TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $207,179 | -100.0% | 5,494 | -35.2% | 0.00% | – |
| Q4 2021 | $425,083,000 | -26.0% | 8,483 | -6.1% | 0.00% | – |
| Q3 2021 | $574,706,000 | +186.2% | 9,032 | +223.6% | 0.00% | – |
| Q2 2021 | $200,840,000 | -45.0% | 2,791 | -43.6% | 0.00% | – |
| Q1 2021 | $365,063,000 | +24.4% | 4,950 | +23.8% | 0.00% | – |
| Q4 2020 | $293,460,000 | -86.5% | 3,997 | -79.3% | 0.00% | -100.0% |
| Q3 2017 | $2,178,298,000 | +0.7% | 19,330 | +0.2% | 0.00% | 0.0% |
| Q2 2017 | $2,162,310,000 | -3.7% | 19,296 | +0.2% | 0.00% | 0.0% |
| Q1 2017 | $2,245,752,000 | +148723.9% | 19,257 | +34.3% | 0.00% | 0.0% |
| Q4 2016 | $1,509,000 | -30.7% | 14,335 | -27.3% | 0.00% | 0.0% |
| Q3 2016 | $2,179,000 | +4.9% | 19,719 | +38.1% | 0.00% | 0.0% |
| Q2 2016 | $2,078,000 | +350.8% | 14,274 | +343.2% | 0.00% | +100.0% |
| Q1 2016 | $461,000 | -4.4% | 3,221 | +3.2% | 0.00% | 0.0% |
| Q4 2015 | $482,000 | – | 3,121 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL LP | 1,104,068 | $104,886,000 | 77.66% |
| Greywolf Capital Management LP | 472,135 | $46,694,000 | 10.17% |
| Consonance Capital Management LP | 263,732 | $26,083,000 | 4.28% |
| Moab Capital Partners | 83,132 | $8,222,000 | 3.77% |
| Raging Capital Management, LLC | 190,151 | $18,806,000 | 3.45% |
| Valentine Capital Asset Management, Inc. | 145,053 | $14,346,000 | 3.07% |
| Assured Investment Management LLC | 1,353,342 | $133,846,000 | 1.21% |
| Ativo Capital Management LLC | 22,828 | $2,258,000 | 0.99% |
| Perceptive Advisors | 56,602 | $5,598,000 | 0.67% |
| Jaffetilchin Investment Partners, LLC | 7,721 | $764,000 | 0.38% |